Pulmonary Drug Delivery Technologies Market to $19.1 Billion by 2010 According to New Report by Global Industry Analysts Inc.



The attractiveness of pulmonary delivery of drugs for the treatment of respiratory diseases stems from the fact that topical drug deposition to infected lung gives a fast therapeutic effect and reduces side effects associated with key drugs. Among the segments analyzed, Metered Dose Inhalers (MDI) market (



Pulmonary Drug Delivery Technologies Market to $19.1 Billion by 2010 According to New Report by Global Industry Analysts Inc.